Company Filing History:
Years Active: 2014-2018
Title: Innovations by Julen Oyarzabal Santamarina
Introduction
Julen Oyarzabal Santamarina is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of biomedical research, particularly in the development of treatments for obesity and cancer. With a total of 2 patents, his work reflects a commitment to advancing medical science.
Latest Patents
One of his latest patents is titled "Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and Ageing." This invention focuses on a phosphoinositide 3-kinase inhibitor that can be used to treat or prevent diseases associated with the expression of specific proteins in brown adipocytes. These diseases include obesity, steatosis, and biological aging. Another significant patent is "Imidazopyrazines for Use as Kinase Inhibitors." This patent describes compounds that are useful in treating diseases where inhibition of protein or lipid kinases is required, particularly in cancer treatment.
Career Highlights
Julen has worked with prestigious institutions such as the National Center for Cancer Research (CNIO) and the Carlos III Health Institute. His research has contributed to the understanding and treatment of various diseases, showcasing his expertise in the field.
Collaborations
Throughout his career, Julen has collaborated with notable colleagues, including Joaquin Pastor Fernández and Sonia Martínez Gonzalez. These partnerships have enhanced his research and innovation efforts.
Conclusion
Julen Oyarzabal Santamarina is a prominent figure in the field of biomedical innovation, with a focus on developing treatments for obesity and cancer. His patents and collaborations reflect his dedication to improving health outcomes through scientific research.